SESSION XIV: NEXT QUESTIONS

Session Chairs: Phillip Scheinberg, MD, PhD and Hagop Kantarjian, MD

Next Questions: Acute Lymphoblastic Leukemia | Elias Jabbour, MD | MD Anderson Cancer Center, Houston, Texas, USA

Next Questions: Acute Myeloid Leukemia | Farhad Ravandi, MD | MD Anderson Cancer Center, Houston, Texas, USA

Next Questions: Cellular Therapy | Jae Park, MD | Memorial Sloan Kettering Cancer Center, New York, New York, USA

Next Questions: Chronic Lymphocytic Leukemia | Alessandra Tedeschi, MD | Niguarda Cancer Center, Milan, Italy

Next Questions: Chronic Myeloid Leukemia | Michael J. Mauro, MD, PhD | Memorial Sloan Kettering Cancer Center, New York, New York, USA

Next Questions: Aggressive B-Cell Lymphoma | Grzegorz S. Nowakowski, MD | Mayo Clinic Rochester, Rochester, Minnesota, USA

Next Questions: Indolent B-Cell Lymphoma | Elizabeth Budde, MD, PhD | City of Hope, Duarte, California, USA

Next Questions: T-Cell Lymphoma | Lauren C. Pinter-Brown, MD | UCI Health, Orange, California, USA

Next Questions: Mantle Cell Lymphoma | Tycel J. Phillips, MD | City of Hope, Duarte, California, USA

Next Questions: Hodgkin Lymphoma | Jonathan W. Friedberg, MD, MMSc | University of Rochester Medical Center, Rochester, Minnesota, USA

Next Questions: Multiple Myeloma | Thomas G. Martin, MD | University of California, San Francisco, California, USA

Next Questions: Myelodysplastic Syndromes | Guillermo Garcia-Manero, MD | MD Anderson Cancer Center, Houston, Texas, USA

Next Questions: Myeloproliferative Neoplasms | Francesco Passamonti, MD | University of Milan, Milan, Italy

Closing Remarks | Drawing | Phillip Scheinberg, MD, PhD | President, Society of Hematologic Oncology